$PMVC
PMV Consumer Acquisition Corp. Stock $pmvc

$pmvc Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000121390022072151 Filed on November 14, 2022

Income Statement

Concept	2022 Q3	2021 Q4	2021 Q3
Revenue	$4.594M	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$351.8K	$94.56K	$111.3K
YoY Change	216.11%	-27.26%	1012.9%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$411.8K	$144.6K	$148.1K
YoY Change	178.0%	-19.67%	34.66%
Operating Profit	-$411.8K		-$148.1K
YoY Change	178.01%
Interest Expense	$1.655M	$541.0K	$3.458M
YoY Change	-52.13%	-280.34%
% of Operating Profit
Other Income/Expense, Net	$4.594M	$0.00	$0.00
YoY Change		-100.0%
Pretax Income	$5.837M	$396.5K	$3.310M
YoY Change	76.37%	-146.64%	-3108.78%
Income Tax	$117.6K	$0.00	$0.00
% Of Pretax Income	2.01%	0.0%	0.0%
Net Earnings	$5.720M	$396.5K	$3.310M
YoY Change	72.81%	-146.64%	-3108.78%
Net Earnings / Revenue	124.51%
Basic Earnings Per Share
Diluted Earnings Per Share	$267.7K	$18.12K	$151.3K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept	2022 Q3	2021 Q4	2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.436M	$1.513M	$1.571M
YoY Change	-8.56%	-24.38%	-43.9%
Cash & Equivalents	$1.436M	$1.512M	$1.571M
Short-Term Investments
Other Short-Term Assets	$100.4K	$103.1K	$139.0K
YoY Change	-27.81%	-65.64%
Inventory
Prepaid Expenses	$100.4K	$103.1K
Receivables
Other Receivables
Total Short-Term Assets	$1.537M	$1.616M	$1.710M
YoY Change	-10.12%	-29.76%	-41.04%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$21.57M	$175.1M	$175.1M
YoY Change	-87.68%	0.06%	0.05%
Other Assets
YoY Change
Total Long-Term Assets	$21.57M	$175.1M	$175.1M
YoY Change	-87.68%	0.06%	0.05%
TOTAL ASSETS
Total Short-Term Assets	$1.537M	$1.616M	$1.710M
Total Long-Term Assets	$21.57M	$175.1M	$175.1M
Total Assets	$23.10M	$176.7M	$176.8M
YoY Change	-86.93%	-0.32%	-0.62%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses	$581.3K	$256.2K	$205.8K
YoY Change	182.53%	28.1%	-58.85%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$603.5K	$256.2K	$205.8K
YoY Change	193.3%	28.1%	-65.71%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$2.203M	$15.66M	$16.18M
YoY Change	-86.38%	-26.47%	165.24%
Total Long-Term Liabilities	$2.203M	$15.66M	$16.18M
YoY Change	-86.38%	-26.47%	165.24%
TOTAL LIABILITIES
Total Short-Term Liabilities	$603.5K	$256.2K	$205.8K
Total Long-Term Liabilities	$2.203M	$15.66M	$16.18M
Total Liabilities	$2.806M	$15.92M	$16.39M
YoY Change	-82.87%	-25.96%	140.96%
SHAREHOLDERS EQUITY
Retained Earnings	-$820.2K	-$14.19M
YoY Change
Common Stock	$0.00	$0.00	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$217.6K	-$14.19M	$160.4M
YoY Change
Total Liabilities & Shareholders Equity	$23.10M	$176.7M	$176.8M
YoY Change	-86.93%	-0.32%	-0.62%

Cashflow Statement

Concept	2022 Q3	2021 Q4	2021 Q3
OPERATING ACTIVITIES
Net Income	$5.720M	$396.5K	$3.310M
YoY Change	72.81%	-146.64%	-3108.78%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$406.1K	-$58.19K	-$55.89K
YoY Change	626.59%	-80.6%	179.45%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$155.5M	$0.00	$0.00
YoY Change			-100.0%
Cash From Investing Activities	$155.5M	$0.00	$0.00
YoY Change			-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-154.9M	0.000	0.000
YoY Change		-100.0%	-100.0%
NET CHANGE
Cash From Operating Activities	-406.1K	-58.19K	-55.89K
Cash From Investing Activities	155.5M	0.000	0.000
Cash From Financing Activities	-154.9M	0.000	0.000
Net Change In Cash	267.4K	-58.19K	-55.89K
YoY Change	-578.46%	-93.07%	-101.98%
FREE CASH FLOW
Cash From Operating Activities	-$406.1K	-$58.19K	-$55.89K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-39534
	dei	Entity Registrant Name EntityRegistrantName	PMV Consumer Acquisition Corp.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	84-5174573
	dei	Entity Address Address Line1 EntityAddressAddressLine1	249 Royal Palm Way
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 503
	dei	Entity Address City Or Town EntityAddressCityOrTown	Palm Beach
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33480
	dei	City Area Code CityAreaCode	(561)
	dei	Local Phone Number LocalPhoneNumber	318-3766
	dei	Security12b Title Security12bTitle	Class A Common Stock, par value $0.0001 per share
	dei	Trading Symbol TradingSymbol	PMVC
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	true
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1436262	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1512496	usd
CY2022Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	100359	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	103084	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	1536621	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	1615580	usd
CY2022Q3	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	21565725	usd
CY2021Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	175109162	usd
CY2022Q3	us-gaap	Assets Assets	23102346	usd
CY2021Q4	us-gaap	Assets Assets	176724742	usd
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	581306	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	256203	usd
CY2022Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	22160	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	603466	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	256203	usd
CY2022Q3	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	1531250	usd
CY2021Q4	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	6125000	usd
CY2022Q3	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	671615	usd
CY2021Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	9537845	usd
CY2022Q3	us-gaap	Liabilities Liabilities	2806331	usd
CY2021Q4	us-gaap	Liabilities Liabilities	15919048	usd
CY2022Q3	us-gaap	Redeemable Noncontrolling Interest Equity Common Carrying Amount RedeemableNoncontrollingInterestEquityCommonCarryingAmount	20513565	usd
CY2021Q4	us-gaap	Redeemable Noncontrolling Interest Equity Common Carrying Amount RedeemableNoncontrollingInterestEquityCommonCarryingAmount	175000000	usd
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2022Q3	pmvc	Common Stock Value One CommonStockValueOne	437	usd
CY2021Q4	pmvc	Common Stock Value One CommonStockValueOne	437	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	602197	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	66	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-820184	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-14194809	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-217550	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-14194306	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	23102346	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	176724742	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	351802	usd
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	111293	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	812559	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	399783	usd
CY2022Q3	pmvc	Franchise Tax Expense FranchiseTaxExpense	60000	usd
CY2021Q3	pmvc	Franchise Tax Expense FranchiseTaxExpense	36831	usd
	pmvc	Franchise Tax Expense FranchiseTaxExpense	160000	usd
	pmvc	Franchise Tax Expense FranchiseTaxExpense	149974	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-411802	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-148124	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-972559	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-549757	usd
CY2022Q3	us-gaap	Interest Income Securities Other Us Government InterestIncomeSecuritiesOtherUSGovernment	686865	usd
CY2021Q3	us-gaap	Interest Income Securities Other Us Government InterestIncomeSecuritiesOtherUSGovernment	9320	usd
	us-gaap	Interest Income Securities Other Us Government InterestIncomeSecuritiesOtherUSGovernment	1014364	usd
	us-gaap	Interest Income Securities Other Us Government InterestIncomeSecuritiesOtherUSGovernment	44344	usd
CY2022Q3	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	968360	usd
CY2021Q3	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	3448467	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	8866230	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	5143432	usd
CY2022Q3	pmvc	Forgiveness Of Deferred Underwriting Fee Payable ForgivenessOfDeferredUnderwritingFeePayable	4593750	usd
	pmvc	Forgiveness Of Deferred Underwriting Fee Payable ForgivenessOfDeferredUnderwritingFeePayable	4593750	usd
CY2022Q3	us-gaap	Other Income OtherIncome	6248975	usd
CY2021Q3	us-gaap	Other Income OtherIncome	3457787	usd
	us-gaap	Other Income OtherIncome	14474344	usd
	us-gaap	Other Income OtherIncome	5187776	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	5837173	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3309663	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	13501785	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	4638019	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	117605	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	127160	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	5719568	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	3309663	usd
	us-gaap	Net Income Loss NetIncomeLoss	13374625	usd
	us-gaap	Net Income Loss NetIncomeLoss	4638019	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-14194306	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	5450898	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-8743408	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	2204159	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-6539249	usd
CY2022Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	990000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	5719568	usd
CY2022Q3	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	-387869	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-217550	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-19228771	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-420832	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	-19649603	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	1749188	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	-17900415	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	3309663	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	-14590752	usd
	us-gaap	Profit Loss ProfitLoss	13374625	usd
	us-gaap	Profit Loss ProfitLoss	4638019	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	1014364	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	44344	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-8866230	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-5143432	usd
	pmvc	Adjustment Of Forgiveness Of Deferred Underwriting Payable AdjustmentOfForgivenessOfDeferredUnderwritingPayable	4593750	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-2725	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-123501	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	22160	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	325103	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-8279	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-749731	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-434535	usd
	pmvc	Cash Withdrawn From Trust Account To Reimburse Expenses CashWithdrawnFromTrustAccountToReimburseExpenses	673497	usd
	pmvc	Cash Withdrawn From Trust Account To Redeeming Investors CashWithdrawnFromTrustAccountToRedeemingInvestors	154874304	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	155547801	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	154874304	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-154874304	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-76234	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-434535	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1512496	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2005228	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1436262	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1570693	usd
	pmvc	Contribution Of Class B Common Stock To The Trust Account ContributionOfClassBCommonStockToTheTrustAccount	990000	usd
	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	9957390	usd
	us-gaap	Expense Related To Distribution Or Servicing And Underwriting Fees ExpenseRelatedToDistributionOrServicingAndUnderwritingFees	3500000	usd
	pmvc	Warrants Price Per Share WarrantsPricePerShare	18
CY2022Q3	pmvc	Market Value Issuance Percentage MarketValueIssuancePercentage	1.80	pure
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i><span style="text-decoration:underline">Use of Estimates</span></i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The preparation of condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of expenses during the reporting period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these condensed financial statements is the determination of the fair value of the warrant liabilities. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p>
CY2021	us-gaap	Gross Profit GrossProfit	175000000	usd
CY2021	pmvc	Proceeds Allocated To Public Warrants ProceedsAllocatedToPublicWarrants	-8837500	usd
CY2021	pmvc	Class A Shares Offering Costs ClassASharesOfferingCosts	-9454542	usd
CY2021	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	18292042	usd
CY2021	pmvc	Class A Common Stock Subject To Possible Redemptionin Shares ClassACommonStockSubjectToPossibleRedemptioninShares	175000000	usd
	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	-154874304	usd
	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	387869	usd
	pmvc	Class A Common Stock Subject To Possible Redemptionin Shares ClassACommonStockSubjectToPossibleRedemptioninShares	20513565	usd
CY2022Q3	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	301936	usd
CY2022Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	301936	usd
CY2022Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	301936	usd
CY2022Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	0	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	248838	usd
	pmvc	Ownership Interest Percentage OwnershipInterestPercentage	0.50	pure
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0	pure
	pmvc	Effective Income Tax Rate Reconciliation Permanent Book Tax Differences EffectiveIncomeTaxRateReconciliationPermanentBookTaxDifferences	0.205	pure
	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.013	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.018	pure
CY2020Q3	pmvc	Aggregate Offering Cost AggregateOfferingCost	9957390	usd
CY2020Q3	pmvc	Payments For Underwriting Expenses PaymentsForUnderwritingExpenses	3500000	usd
CY2020Q3	pmvc	Deferred Underwriting Fees DeferredUnderwritingFees	6125000	usd
CY2020Q3	pmvc	Other Offering Costs OtherOfferingCosts	507390	usd
CY2020Q3	pmvc	Underwriting Gross Proceeds UnderwritingGrossProceeds	175000	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i><span style="text-decoration:underline">Concentration of Credit Risk</span></i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"> </span></p>
	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	250000	usd
CY2020Q3	us-gaap	Stockholders Equity Note Stock Split StockholdersEquityNoteStockSplit	On August 3, 2020, the Company effected a 1.4-for-1 forward stock split of its issued and outstanding shares of Class B convertible common stock, resulting in an aggregate of 5,031,250 Founder Shares being outstanding, of which an aggregate of up to 656,250 shares were subject to forfeiture by the Sponsor to the extent that the underwriters’ over-allotment option was not exercised in full or in part so that the Sponsor would own, on an as-converted basis, 20% of the Company’s issued and outstanding shares after the Initial Public Offering (assuming the Sponsor did not purchase any Public Shares in the Initial Public Offering).
	pmvc	Sale Of Stock Number Of Share Issued In Transactions SaleOfStockNumberOfShareIssuedInTransactions	17500000	shares
CY2022Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	10
CY2022Q3	pmvc	Sponsor Owned Shares SponsorOwnedShares	4175000	shares
CY2020Q3	pmvc	Administrative Fees AdministrativeFees	10000	usd
CY2022Q3	us-gaap	Investment Company Shareholder Service Fee Expense InvestmentCompanyShareholderServiceFeeExpense	30000	usd
	us-gaap	Investment Company Shareholder Service Fee Expense InvestmentCompanyShareholderServiceFeeExpense	30000	usd
CY2021Q3	us-gaap	Investment Company Shareholder Service Fee Expense InvestmentCompanyShareholderServiceFeeExpense	90000	usd
	us-gaap	Investment Company Shareholder Service Fee Expense InvestmentCompanyShareholderServiceFeeExpense	90000	usd
CY2022Q3	us-gaap	Accrued Liabilities For Commissions Expense And Taxes AccruedLiabilitiesForCommissionsExpenseAndTaxes	242000	usd
CY2021Q4	us-gaap	Accrued Liabilities For Commissions Expense And Taxes AccruedLiabilitiesForCommissionsExpenseAndTaxes	152000	usd
	pmvc	Underwriting Deferred Fee UnderwritingDeferredFee	0.35
CY2022Q3	us-gaap	Investment Banking Advisory Brokerage And Underwriting Fees And Commissions InvestmentBankingAdvisoryBrokerageAndUnderwritingFeesAndCommissions	4593750	usd
CY2022Q3	us-gaap	Net Investment Income NetInvestmentIncome	4593750	usd
	us-gaap	Payments For Underwriting Expense PaymentsForUnderwritingExpense	1531250	usd
CY2021	us-gaap	Payments For Underwriting Expense PaymentsForUnderwritingExpense	6125000	usd
CY2022Q3	pmvc	Excise Tax Percentage ExciseTaxPercentage	0.01	pure
	pmvc	Excise Tax Percentage ExciseTaxPercentage	0.01	pure
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased	20000000	shares
	pmvc	Shares Outstanding Percentage Of Initial Public Offering SharesOutstandingPercentageOfInitialPublicOffering	0.20	pure
CY2022Q3	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P5Y
	pmvc	Warrants For Redemption Description WarrantsForRedemptionDescription	●in whole and not in part; ●at a price of $0.01 per warrant; ●upon not less than 30 days’ prior written notice of redemption; ●if, and only if, the reported last sale price of the Company’s common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like and subject to adjustment as described below) for any 20 trading days within a 30-trading day period ending on the third business day prior to the notice of redemption to the warrant holders; and ●If, and only if, there is a current registration statement in effect with respect to the shares of common stock underlying the warrants.
CY2022Q3	pmvc	Effective Issue Prices EffectiveIssuePrices	9.2
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Per Share Weighted Average Price Of Shares Purchased ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased	9.2
	pmvc	Fair Market Value Percentage FairMarketValuePercentage	1.15	pure
	us-gaap	Other Underwriting Expense OtherUnderwritingExpense	6125000	usd
CY2022Q3	us-gaap	Other Ownership Interests Offering Costs OtherOwnershipInterestsOfferingCosts	507390	usd
	pmvc	Offset Credit By Underwriters OffsetCreditByUnderwriters	175000	usd
CY2022Q3	us-gaap	Cash Cash	1436262	usd
CY2020Q3	us-gaap	Sale Of Stock Description Of Transaction SaleOfStockDescriptionOfTransaction	Following the closing of the Initial Public Offering on September 24, 2020, an amount of $175,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Warrants was placed in a trust account (the “Trust Account”) located in the United States, which will only be invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 180 days or less or in any open-end investment company that holds itself out as a money market fund selected by the Company meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account, as described below.
	pmvc	Business Combination Fair Market Value Percentage BusinessCombinationFairMarketValuePercentage	0.80	pure
	pmvc	Percentage Of Outstanding Voting Securities PercentageOfOutstandingVotingSecurities	0.50	pure
	pmvc	Public Share Price Per Share PublicSharePricePerShare	10
CY2022Q3	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	5000001	usd
CY2022Q3	pmvc	Net Tangible Book Value NetTangibleBookValue	5000001	usd
CY2022Q3	pmvc	Public Share Percentage PublicSharePercentage	0.20	pure
CY2022Q3	pmvc	Public Shares Redeem Percentage PublicSharesRedeemPercentage	1	pure
CY2022Q3	us-gaap	Common Stock Other Shares Outstanding CommonStockOtherSharesOutstanding	200000	shares
CY2022Q3	us-gaap	Treasury Stock Preferred Shares TreasuryStockPreferredShares	20000000	shares
CY2022Q3	us-gaap	Sale Of Stock Percentage Of Ownership After Transaction SaleOfStockPercentageOfOwnershipAfterTransaction	0.20	pure
CY2022Q3	pmvc	Stockholders Holding Description StockholdersHoldingDescription	At the special meeting of stockholders on September 21, 2022, in connection with the extension, stockholders holding 15,453,391 shares of Class A common stock exercised their right to redeem such shares for a pro rata portion of the funds in the Trust Account. As a result, $154,874,303 (approximately $10.02 per share), which included $340,393 of interest earned on the Trust Account which was not previously used to pay the Company’s tax obligation, was removed from the Trust Account to pay such holders. Following these redemptions, the Company had 2,046,609 shares of Class A common stock outstanding and the aggregate amount remaining in the Trust Account at the time was $20,511,170.
	pmvc	Public Price Per Share PublicPricePerShare	10
	pmvc	Reduction Per Shares ReductionPerShares	10	usd
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i><span style="text-decoration:underline">Reclassifications</span></i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">Certain reclassifications have been made to the historical financial statements to conform to the current year’s presentation. Certain balances in the September 30, 2021 cash flow have been presented on a net basis to conform to the current period presentation. Such reclassifications have no effect on net income as previously reported.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"> </span></p>
CY2022Q3	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	21565725	usd
CY2022Q3	pmvc	Warrant Liability Public Warrants WarrantLiabilityPublicWarrants	378875	usd
CY2022Q3	pmvc	Warrant Liability Private Placement Warrants WarrantLiabilityPrivatePlacementWarrants	292740	usd
CY2021Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	175109162	usd
CY2021Q4	pmvc	Warrant Liability Public Warrants WarrantLiabilityPublicWarrants	5600000	usd
CY2021Q4	pmvc	Warrant Liability Private Placement Warrants WarrantLiabilityPrivatePlacementWarrants	3937845	usd
CY2022Q3	us-gaap	Fair Value Concentration Of Risk Cash And Cash Equivalents FairValueConcentrationOfRiskCashAndCashEquivalents	0	usd
CY2021Q4	us-gaap	Fair Value Concentration Of Risk Cash And Cash Equivalents FairValueConcentrationOfRiskCashAndCashEquivalents	195	usd
CY2022Q3	us-gaap	Interest And Other Income InterestAndOtherIncome	673497	usd
	us-gaap	Interest And Other Income InterestAndOtherIncome	673497	usd
CY2022Q3	us-gaap	Share Price SharePrice	9.9
CY2021Q4	us-gaap	Share Price SharePrice	9.83
CY2022Q3	pmvc	Fair Value Measurement Strike Price FairValueMeasurementStrikePrice	11.5
CY2021Q4	pmvc	Fair Value Measurement Strike Price FairValueMeasurementStrikePrice	11.5
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.0103	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.1367	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0412	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0071	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022Q3	pmvc	Business Combination Step Acquisition Equity Interest In Acquiree Percentage1 BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage1	0.50	pure
CY2021Q4	pmvc	Business Combination Step Acquisition Equity Interest In Acquiree Percentage1 BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage1	0.70	pure
	pmvc	Fair Value Initial Measurement FairValueInitialMeasurement	14864500	usd
CY2020Q4	pmvc	Change In Fair Value Recognized In Earnings ChangeInFairValueRecognizedInEarnings	333500	usd
CY2020Q4	pmvc	Fair Value Of Warrant Liabilities FairValueOfWarrantLiabilities	15198000	usd
CY2021Q1	pmvc	Change In Fair Value Recognized In Earnings ChangeInFairValueRecognizedInEarnings	236500	usd
CY2021Q1	pmvc	Fair Value Of Warrant Liabilities FairValueOfWarrantLiabilities	15434500	usd
CY2021Q2	pmvc	Change In Fair Value Recognized In Earnings ChangeInFairValueRecognizedInEarnings	-1931465	usd
CY2021Q2	pmvc	Fair Value Of Warrant Liabilities FairValueOfWarrantLiabilities	13503035	usd
CY2021Q3	pmvc	Change In Fair Value Recognized In Earnings ChangeInFairValueRecognizedInEarnings	-3448467	usd
CY2021Q3	pmvc	Fair Value Of Warrant Liabilities FairValueOfWarrantLiabilities	10054568	usd
CY2021Q4	pmvc	Transfer Of Public Warrants To Level1 TransferOfPublicWarrantsToLevel1	-5929000	usd
CY2021Q4	pmvc	Change In Fair Value Recognized In Earnings ChangeInFairValueRecognizedInEarnings	-187723	usd
CY2021Q4	pmvc	Fair Value Of Warrant Liabilities FairValueOfWarrantLiabilities	3937845	usd
CY2022Q1	pmvc	Change In Fair Value Recognized In Earnings ChangeInFairValueRecognizedInEarnings	-2338845	usd
CY2022Q1	pmvc	Fair Value Of Warrant Liabilities FairValueOfWarrantLiabilities	1599000	usd
CY2022Q2	pmvc	Change In Fair Value Recognized In Earnings ChangeInFairValueRecognizedInEarnings	-921526	usd
CY2022Q2	pmvc	Fair Value Of Warrant Liabilities FairValueOfWarrantLiabilities	677474	usd
CY2022Q3	pmvc	Change In Fair Value Recognized In Earnings ChangeInFairValueRecognizedInEarnings	-384734	usd
CY2022Q3	pmvc	Fair Value Of Warrant Liabilities FairValueOfWarrantLiabilities	292740	usd
CY2022Q3	pmvc	Aggregate Share AggregateShare	200000	shares
CY2021Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent		usd
CY2022Q3	us-gaap	Common Stock Value CommonStockValue		usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue		usd
CY2022Q3	pmvc	Common Stock Value Two CommonStockValueTwo		usd
CY2021Q4	pmvc	Common Stock Value Two CommonStockValueTwo		usd
CY2022Q3	pmvc	Common Stock Value Three CommonStockValueThree		usd
CY2021Q4	pmvc	Common Stock Value Three CommonStockValueThree		usd
CY2021Q3	pmvc	Forgiveness Of Deferred Underwriting Fee Payable ForgivenessOfDeferredUnderwritingFeePayable		usd
	pmvc	Forgiveness Of Deferred Underwriting Fee Payable ForgivenessOfDeferredUnderwritingFeePayable		usd
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable		usd
	pmvc	Cash Withdrawn From Trust Account To Reimburse Expenses CashWithdrawnFromTrustAccountToReimburseExpenses		usd
	pmvc	Cash Withdrawn From Trust Account To Redeeming Investors CashWithdrawnFromTrustAccountToRedeemingInvestors		usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock		usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
	pmvc	Contribution Of Class B Common Stock To The Trust Account ContributionOfClassBCommonStockToTheTrustAccount		usd
CY2022Q3	us-gaap	Deferred Costs And Other Assets DeferredCostsAndOtherAssets		usd
CY2022Q3	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2020Q1	pmvc	Fair Value Of Warrant Liabilities FairValueOfWarrantLiabilities		usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001807765

Files In Submission

Name	View Source	Status
f10q0922_pmvconsumer_htm.xml	Edgar Link	completed
pmvc-20220930_lab.xml	Edgar Link	unprocessable
pmvc-20220930_def.xml	Edgar Link	unprocessable
pmvc-20220930_pre.xml	Edgar Link	unprocessable
0001213900-22-072151-index-headers.html	Edgar Link	pending
0001213900-22-072151-index.html	Edgar Link	pending
0001213900-22-072151.txt	Edgar Link	pending
0001213900-22-072151-xbrl.zip	Edgar Link	pending
f10q0922ex31-1_pmvconsumer.htm	Edgar Link	pending
f10q0922ex31-2_pmvconsumer.htm	Edgar Link	pending
f10q0922ex31-3_pmvconsumer.htm	Edgar Link	pending
f10q0922ex32-1_pmvconsumer.htm	Edgar Link	pending
f10q0922ex32-2_pmvconsumer.htm	Edgar Link	pending
f10q0922ex32-3_pmvconsumer.htm	Edgar Link	pending
f10q0922_pmvconsumer.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
pmvc-20220930.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
pmvc-20220930_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PMVC
PMV Consumer Acquisition Corp. Stock $pmvc

2022 Q3 Form 10-Q Financial Statement

#000121390022072151 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PMVC PMV Consumer Acquisition Corp. Stock $pmvc

2022 Q3 Form 10-Q Financial Statement

#000121390022072151 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PMVC
PMV Consumer Acquisition Corp. Stock $pmvc